Assessment of the toxicological impacts of fine particles (PM 2.5) and nanoparticles of environmental origin in the pathogenesis of chronic bronchopneumopathies (COPD, asthma).
Assessment of the toxicological impacts of fine particles (PM 2.5) and nanoparticles of environmental origin in the pathogenesis of chronic bronchopneumopathies (COPD, asthma).